Poolbeg Pharma's (Poolbeg Pharma PLC (AIM:POLB)) Jeremy Skillington joins Proactive London' to talk about the details of their agreement to develop an oral vaccine delivery platform.
The firm has signed a binding term sheet with AnaBio Technologies, with a full licence and collaboration agreement to follow.
The partnership allows Poolbeg exclusive access to AnaBio's microencapsulation and nanoencapsulation technologies, IP and expertise for oral vaccine applications.
